PIRS - Pieris Pharmaceuticals Inc
IEX Last Trade
18.055
-0.415 -2.299%
Share volume: 9,135
Last Updated: Fri 30 Aug 2024 08:44:37 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$18.47
-0.42
-2.25%
Summary score
22%
Profitability
25%
Dept financing
12%
Liquidity
49%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-26.4%
Return on assets
-9.06%
Return on sales
-951.51%
Return on invested capital
20.01%
Total debt ratio
60.05%
Debt ratio change over timeo
-0.5%
Current Ratio
2.9%
Quick Ratio
2.76%
Cash Position Ratio
2.32%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-16.21%
Return on assets
-6.15%
Return on sales
-2600.4%
Return on invested capital
27.78%
Total debt ratio
39.68%
Debt ratio change over timeo
-0.42%
Current Ratio
2.79%
Quick Ratio
2.79%
Cash Position Ratio
1.97%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-22.27%
Return on assets
-17.98%
Return on sales
-10005.66%
Return on invested capital
64.94%
Total debt ratio
25.54%
Debt ratio change over time
-0.34%
Current Ratio
3.92%
Quick Ratio
3.92%
Cash Position Ratio
2.53%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-105.09%
Return on assets
-108.15%
Return on sales
-1950.31%
Return on invested capital
-41.34%
Total debt ratio
-49.86%
Debt ratio change over time
-0.5%
Current Ratio
1.7%
Quick Ratio
2.34%
Cash Position Ratio
1.36%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | PIRS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -26.4% | 13.79% | 34.47% | 7.43% |
| Return on assets | -9.06% | 2.76% | 3.15% | 5.62% |
| Return on sales | -951.51% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 20.01% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 43% | 66% | 80% |
| Total debt ratio | 60.05% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -0.5% | 308.97% | -6.99% | 1.18% |
| Dept financing | 17% | 50% | 25% | 7% |
| Current Ratio | 2.79% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 2.79% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 1.97% | 0.36% | 1.28% | 2.93% |
| Liquididy | 60% | 14% | 31% | 72% |
| Short-term ratios | PIRS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -16.21% | 13.77% | 13.25% | 3.8% |
| Return on assets | -6.15% | 2.43% | 1.89% | 3.09% |
| Return on sales | -2600.4% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 27.78% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 67% | 62% | 65% |
| Total debt ratio | 39.68% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -0.42% | 46.38% | -72.08% | 1.51% |
| Dept financing | 11% | 50% | 25% | 7% |
| Current Ratio | 2.79% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 2.79% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 1.97% | 0.36% | 1.28% | 2.93% |
| Liquididy | 45% | 12% | 31% | 75% |